Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Chanbin Lee, Ji‐Eun Kim, Youngmi Jung
Cells (2019) Vol. 8, Iss. 10, pp. 1259-1259
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease
Meixi Wang, Zong‐Gen Peng
Pharmacology & Therapeutics (2023) Vol. 246, pp. 108428-108428
Closed Access | Times Cited: 10
A review of experimental and clinical studies on the therapeutic effects of pomegranate (Punica granatum) on non‐alcoholic fatty liver disease: Focus on oxidative stress and inflammation
Mohammad Yasin Zamanian, Mehraveh Sadeghi Ivraghi, Lusine Khachatryan, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 12, pp. 7485-7503
Open Access | Times Cited: 10
The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes
Maobin Kuang, Jiajun Qiu, Dongdong Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Phthalate Biomarkers Composition in Relation to Fatty Liver: Evidence from Epidemiologic and in vivo studies
Shucong Chen, Hang Liu, Yulian Sun, et al.
The Science of The Total Environment (2024) Vol. 924, pp. 171607-171607
Closed Access | Times Cited: 3
The Role of Thyroid Hormones and Autoantibodies in Metabolic Dysfunction Associated Fatty Liver Disease: TgAb May Be a Potential Protective Factor
Xiaofu Zhang, Ruyi Li, Yingjie Chen, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 24
Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
Sherouk Fouda, Madhu Vennikandam, Joseph M. Pappachan, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 947-954
Open Access | Times Cited: 14
Estrogens in Hepatocellular Carcinoma: Friends or Foes?
Giuseppe Carruba
Cancers (2021) Vol. 13, Iss. 9, pp. 2085-2085
Open Access | Times Cited: 18
The portrait of liver cancer is shaped by mitochondrial genetics
Mrittika Chattopadhyay, Edmund C. Jenkins, Ana Victoria Lechuga‐Vieco, et al.
Cell Reports (2022) Vol. 38, Iss. 3, pp. 110254-110254
Open Access | Times Cited: 13
J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes
Cuiling Zhu, Huihui Ma, Dongdong Huang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 13
Associations of Sex Steroids and Sex Hormone-Binding Globulin with Non-Alcoholic Fatty Liver Disease: A Population-Based Study and Meta-Analysis
Xiaofang Zhang, Yuchan Mou, Elif Aribas, et al.
Genes (2022) Vol. 13, Iss. 6, pp. 966-966
Open Access | Times Cited: 12
Estrogen receptor activation remodels TEAD1 gene expression to alleviate hepatic steatosis
Christian Sommerauer, Carlos J. Gallardo-Dodd, Christina Savva, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 4, pp. 374-402
Open Access | Times Cited: 2
Protective effects of 17-β-estradiol on liver injury: The role of TLR4 signaling pathway and inflammatory response
Mohammad Khaksari, Mohammadreza Pourali, Saman Rezaei Talabon, et al.
Cytokine (2024) Vol. 181, pp. 156686-156686
Closed Access | Times Cited: 2
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD
Nimish Thakral, Hailemichael Desalegn, Luis Antonio Díaz, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 03, pp. 273-286
Closed Access | Times Cited: 2
Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH
David Montefusco, Maryam Jamil, Melissa A. Maczis, et al.
Molecular Metabolism (2022) Vol. 62, pp. 101523-101523
Open Access | Times Cited: 11
Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis
Mohamed N. Abdelnabi, Manuel Flores Molina, Geneviève Soucy, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 14, Iss. 6, pp. 1269-1294
Open Access | Times Cited: 11
Maternal hepatic immunology during pregnancy
Ling Yang, Meng Yao, Yuxiang Shi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style
Qianying Zuo, Nicole Hwajin Park, Jenna Kathryn Lee, et al.
Steroids (2023) Vol. 203, pp. 109330-109330
Closed Access | Times Cited: 6
Estradiol Protects Female ApoE KO Mice against Western-Diet-Induced Non-Alcoholic Steatohepatitis
Layanne C. C. Araujo, Alessandra G. Cruz, Felipe N. Camargo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9845-9845
Open Access | Times Cited: 5
Non-alcoholic fatty liver disease and women's health
М. А. Ливзан, M.I. Syrovenko, Т. С. Кролевец
Russian Medical Inquiry (2023) Vol. 7, Iss. 5, pp. 310-317
Open Access | Times Cited: 5
A review of the effects of estrogen and epithelial-mesenchymal transformation on intrauterine adhesion and endometriosis
Heyu Liu, Zheng-yan Zhu, Xuemei Chen, et al.
Transplant Immunology (2022) Vol. 79, pp. 101679-101679
Closed Access | Times Cited: 8
Therapeutic Effect and Mechanism Prediction of Fuzi-Gancao Herb Couple on Non-alcoholic Fatty Liver Disease (NAFLD) based on Network Pharmacology and Molecular Docking
Kejia Liu, Xu Yang, Guihong Zhang, et al.
Combinatorial Chemistry & High Throughput Screening (2023) Vol. 27, Iss. 5, pp. 773-785
Closed Access | Times Cited: 4
Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area †
Tanmoy Mondal, Coleman Smith, Christopher A. Loffredo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16654-16654
Open Access | Times Cited: 4
Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study
Xiangming Ma, Jianguo Jia, Haozhe Cui, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, Diagnosis, Treatment, and Outcomes: A Narrative Review
Kaia C. Miller, Brian C. Geyer, Anastasia‐Stefania Alexopoulos, et al.
Digestive Diseases and Sciences (2024)
Closed Access | Times Cited: 1
Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”
Ralf Weiskirchen
Cells (2020) Vol. 9, Iss. 5, pp. 1105-1105
Open Access | Times Cited: 12

Scroll to top